Press releasePRNewswire
A SPAC III Acquisition
ASPCU · NASDAQ
$10.76−$0.46 (−4.10%)TodayMarket closed ·
Prev close $11.22
About ASPCU
- Employees
- 0
- Listed
- Nov 8, 2024
- Sector
- N/A
- Industry
- N/A
ASPCU key statistics
- Market cap
- 24.66M
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 75
- Volume
- 2.10K
- Open price
- $10.81
- High today
- $10.83
- Low today
- $10.76
- 52 Week high
- $49.00
- 52 Week low
- $10.45
A SPAC III Acquisition (ASPCU) at a glance
As of Nov 2, 2026, A SPAC III Acquisition (ASPCU) shares are priced at $10.76, giving the company a market cap of 24.66M and a price-to-earnings ratio of 0.00.
Today the stock has traded between $10.76 and $10.83. The current price is 0.0% above the day's low and 0.6% below its high.
Volume so far is 2.10K shares, above the average of 75 shares a day.
Over the past year A SPAC III Acquisition has ranged from $10.45 to $49.00, and now sits 1% of the way up that range.
ASPCU news
- Press releasePRNewswire
A SPAC III Acquisition Corp. Announces Pricing of $55 Million Initial Public Offering
Most active stocks
Highest trading volume today
- INLFINLIF$0.2899+56.70%
- RBNERobin Energy$0.151+8.95%
- GMZPGemz$0.0001−50.00%
- INTCIntel$59.97−8.80%
- INOInovio Pharmaceuticals$1.90+215.31%
- XXII22nd Century Group$0.0741+6.47%
- NVDGraniteShares ETF Trust$4.54+2.60%
- TMGITransglobal Management Group$0.0001−33.33%
- BDMDBaird Medical Investment Holdings$0.138−13.97%
- SOXLDirexion Shares ETF Trust$68.17−11.52%
- RDARRaadr$0.0002+0.00%
- EARIEntertainment Arts Research$0.0002+0.00%
Newly listed
Companies that went public in the past six weeks
- GBCGEORGIA BANKING$37.28−2.87%
- BHAIUBHAV Acquisition Corp II$10.00+0.15%
- SCQCUSPACCircle Acquisition$9.97−0.15%
- LYCALycia Therapeutics$27.18+2.95%
- DAVIDAVION HEALTHCARE$1.49−11.31%
- TCXBTCGX Acquisition Corp. II$10.10−0.39%
- CTYCITY THERAPEUTICS$20.88+0.82%
- IAMIambic Therapeutics$12.96−3.54%
- AMROAmaero$5.72+2.88%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.16−0.10%
- TRXBTRex Bio$13.64−0.73%
- RTSNRetension Pharmaceuticals$11.30−0.53%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.